S. soldiers receiving Pentostam for the treatment of cutaneous Leishmaniasis were evaluated in our clinic at Walter Reed Army Medical Center after experiencing urticaria, angioedema, wheezing and dyspnea after medication infusion during the 20-day course of daily therapy.